HDAC9 and prostate carcinoma: Studies have also shown that stabilization of p53 at lysine 373, induces cell cycle arrest and apoptosis in LNCaP prostate cancer cells, while TSA an HDAC inhibitor stabilizes the acetylation of p53 at lysine 382 induces only cell cycle arrest in the cell line [12, 44].